Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/21/2012CN101704861B Compound extracted from Tibetan medicine eriophyton wallichii with antioxidant activity and extracting method thereof
03/21/2012CN101704860B Compound extracted from Tibetan medicine eriophyton wallichii with antioxidant activity and extracting method thereof
03/21/2012CN101704859B Compound extracted from Tibetan medicine eriophyton wallichii with antioxidant activity and extracting method thereof
03/21/2012CN101704858B Compound extracted from Tibetan medicine eriophyton wallichii with antioxidant activity and extracting method thereof
03/21/2012CN101700333B Traditional Chinese medicine for treating burns and scalds
03/21/2012CN101700245B Compound drug for curing colds and preparation technology thereof
03/21/2012CN101687800B Glucokinase activator
03/21/2012CN101628905B C-aryl glucoside sglt2 inhibitors and method
03/21/2012CN101622003B Therapeutic agent for ameliorating prognosis after lower limb amputation surgery
03/21/2012CN101610768B Method of inhibiting c kit kinase
03/21/2012CN101610751B Prophylactic or therapeutic agent for alopecia
03/21/2012CN101588792B Nanoemulsion
03/21/2012CN101573336B Chemical compounds of pyridine carboxamide used for 11-beta-HSDI inhibitor
03/21/2012CN101559227B Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions
03/21/2012CN101553216B Treatment of inflammatory diseases
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101491515B Use of paclitaxel in preparing medicine for preventing and treating idiopathic pulmonary fibrosis
03/21/2012CN101490009B Synthesis of acylaminoalkenylene amides useful as substance P antagonists.
03/21/2012CN101466374B Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1(VR1) receptors
03/21/2012CN101455673B Use of cinnamyl-(6'-O-alpha-L- arabopyranose)- O-beta-D-glucopyranoside in preparing antidepressant medicine
03/21/2012CN101443002B Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
03/21/2012CN101437829B Bisadenosine compounds as adenosine A2A receptor agonists
03/21/2012CN101432009B Preventative treatment and remission of allergic diseases
03/21/2012CN101426488B Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
03/21/2012CN101416936B Preparation method of long-acting composite sulfamonomethoxine suspension
03/21/2012CN101406565B Pepper Babu plaster for rheumatism and method for producing the same
03/21/2012CN101379048B Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
03/21/2012CN101375937B Cudrania tricuspidata extract, preparation and application thereof
03/21/2012CN101370505B Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
03/21/2012CN101355952B Compositions useful for reducing nephrotoxicity and methods of use thereof
03/21/2012CN101343331B Synthesis of substituted pachyman
03/21/2012CN101342167B Medicament composition
03/21/2012CN101331112B Biphenyl acetate as well as preparation method and application thereof
03/21/2012CN101310717B preparation method of tanshinone IIA polylactic acid nano particles
03/21/2012CN101298427B Diaryl urea compound and use thereof
03/21/2012CN101292997B Pharmaceutical composition for treating empyrosis or gastric ulcer, and preparation method thereof
03/21/2012CN101277713B Composition for acceleration of type I collagen production
03/21/2012CN101258147B Derivatives of 4-piperazin-1-yl-4-benz0[B]thiophene suitable for the treatment of CNS disorders
03/21/2012CN101249138B Schisandra chinensis ethyl hydrate extract and uses thereof, and anti AIDS pharmaceutical combination
03/21/2012CN101249082B Preparation of acidum citricum tamoxifen polylactic acid-glycolic co-polymer microballoons
03/21/2012CN101237862B Compositions comprising an no donor and a dithiolane and their use for improvement of sexual function
03/21/2012CN101229241B Application of Chinese traditional medicine compounds on preparing medicines promoting mesenchymal stem cells surviving in the body and cardioblast differentiation
03/21/2012CN101214286B Chinese medicine white spirit preparations for effectively treating rheumatic pain diseases
03/21/2012CN101208090B Stabilized composition
03/21/2012CN101203221B Methods and compositions containing natural folates for protecting against radiation damage
03/21/2012CN101199564B Application of sanchi flower total saponine in preparing treatment hypertension disease medicament
03/21/2012CN101184725B N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
03/21/2012CN101184494B Method for preparing and separating phospholipids
03/21/2012CN101181225B System for transferring nanometer polyalcohol micelle medicament and preparing method as well as application thereof
03/21/2012CN101175501B Production of glucosamine from plant species
03/21/2012CN101164543B Acyl pseudopeptides bearing a functionalised auxiliary spacer
03/21/2012CN101161246B New purpose of ginsenoside Rh2
03/21/2012CN101128429B Nk1 antagonists
03/21/2012CN101124206B 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
03/21/2012CN101112369B Application of tanshinol in the preparation of medicine for treating and preventing chronic renal failure and kidney fibrosis
03/21/2012CN101111232B Method for the production of a tamper-proof form of administration
03/21/2012CN101085069B Medicine for curing beriberi
03/21/2012CN101057845B Bulleyaconitin A dry emulsion and its preparation method and application
03/21/2012CN101039900B 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
03/21/2012CN101035795B Thiazolyl-dihydro indazoles
03/21/2012CN101015519B Loratadine oral compound medication composition
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138374 Composition for external application to skin
03/20/2012US8138372 Zwitterionic compounds and use thereof
03/20/2012US8138361 C-10 carbamates of taxanes
03/20/2012US8138360 substrates for amyloidogenic proteins, for example, A beta 1-42, an amyloid protein, brain deposits of which are associated with Alzheimer's disease
03/20/2012US8138357 Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
03/20/2012US8138356 Chemical inhibitors of inhibitors of differentiation
03/20/2012US8138353 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
03/20/2012US8138350 N′-cyano-N-halogenalkylimidamide derivatives
03/20/2012US8138349 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
03/20/2012US8138344 Process for the preparation of rapamycin derivatives
03/20/2012US8138342 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
03/20/2012US8138339 Inhibitors of protein kinases
03/20/2012US8138338 Aurora kinase inhibitors from an encoded small molecule library
03/20/2012US8138337 Reverse-turn mimetics and method relating thereto
03/20/2012US8138336 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
03/20/2012US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
03/20/2012US8138334 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
03/20/2012US8138265 Hydroxyphenyl cross-linked macromolecular network and applications thereof
03/20/2012US8138229 Compositions and methods of delivery of pharmacological agents
03/20/2012US8138228 Liquid kelp formulation with or without enhanced shelf life, and method of making
03/20/2012US8138227 Method for inhibiting or reversing non-enzymatic glycation
03/20/2012US8138226 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
03/20/2012US8138225 Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
03/20/2012US8138224 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
03/20/2012US8138222 Whitening agents for cellulosic substrates
03/20/2012US8138221 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
03/20/2012US8138220 [2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
03/20/2012US8138219 Tryptamine sulfonamides as 5-HT6 antagonists
03/20/2012US8138218 Growth hormone secretagogues
03/20/2012US8138217 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide
03/20/2012US8138216 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
03/20/2012US8138215 Hepatitis C virus inhibitors
03/20/2012US8138214 Pharmaceutical composition
03/20/2012US8138213 Isoxazoline-substituted benzamide compound and pesticide
03/20/2012US8138211 Isothiazolyloxyphenylamidines and their use as fungicides
03/20/2012US8138210 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/20/2012US8138209 Substituted picolinamides as MAO-B inhibitors useful for treating obesity
03/20/2012US8138208 Aminotetrahydroindazoloacetic acids
1 ... 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 ... 7860